These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13908015)

  • 21. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 22. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
    Fischer KG
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
    [No Abstract]   [Full Text] [Related]  

  • 23. HIT/HITT and alternative anticoagulation: current concepts.
    Lakshmanan S; Saha B; Rittoo D
    Br J Anaesth; 2003 Sep; 91(3):445; author reply 445-6. PubMed ID: 12966934
    [No Abstract]   [Full Text] [Related]  

  • 24. [Skin necrosis induced by heparin: apropos of 2 cases].
    Andolfatto S; Latger-Cannard V; Maistre ED; Briquel ME; André E; Montange F; Reichert S; Lecompte T
    Ann Biol Clin (Paris); 2001; 59(5):651-4. PubMed ID: 11602401
    [No Abstract]   [Full Text] [Related]  

  • 25. [Heparin-induced thrombopenia and thrombosis].
    Stöckli TC; Walther A; Görres G; Ritz R; Marbet GA
    Schweiz Med Wochenschr; 1996 Mar; 126(12):483-8. PubMed ID: 8650513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of heparin-induced thrombocytopenia.
    Greinacher A
    Thromb Haemost; 1999 Aug; 82(2):457-67. PubMed ID: 10605737
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of heparin and dextran sulphate on the production of collagen and protein in diabetic and non-diabetic human skin fibroblast cultures.
    Kjellström T; Malmquist J
    Med Biol; 1983 Jun; 61(3):186-90. PubMed ID: 6195494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
    Laposata M; Green D; Van Cott EM; Barrowcliffe TW; Goodnight SH; Sosolik RC
    Arch Pathol Lab Med; 1998 Sep; 122(9):799-807. PubMed ID: 9740137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Argatroban, a new treatment option for heparin-induced thrombocytopenia.
    Cleveland KW
    Crit Care Nurse; 2003 Dec; 23(6):61-6. PubMed ID: 14692173
    [No Abstract]   [Full Text] [Related]  

  • 30. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
    Lindhoff-Last E; Bauersachs R
    Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
    Wilde MI; Markham A
    Drugs; 1997 Dec; 54(6):903-24. PubMed ID: 9421696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fucosylated chondroitin sulfate from echinoderm modulates in vitro fibroblast growth factor 2-dependent angiogenesis.
    Tapon-Bretaudière J; Chabut D; Zierer M; Matou S; Helley D; Bros A; Mourão PA; Fischer AM
    Mol Cancer Res; 2002 Dec; 1(2):96-102. PubMed ID: 12496356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. About oral absorption and human pharmacokinetics of chondroitin sulfate.
    Volpi N
    Osteoarthritis Cartilage; 2010 Aug; 18(8):1104-5; author reply 1106-7. PubMed ID: 20510382
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anticoagulant].
    Mitome J; Yamamoto H
    Nihon Rinsho; 2004 May; 62 Suppl 5():368-73. PubMed ID: 15197947
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of heparin-induced thrombocytopenia.
    Dager WE; White RH
    Ann Pharmacother; 2002 Mar; 36(3):489-503. PubMed ID: 11895064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
    Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
    Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary observations on the treatment of diabetes mellitus with a sulphamide causing hypoglycemia].
    CUGUDDA E; GUAZZI B; MANCINI A
    Minerva Med; 1956 Sep; 47(72):585-7. PubMed ID: 13387149
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].
    Gindre L; de Maistre E; Perrin A; Lecompte T; Hoffman MA
    Therapie; 1997; 52(6):591-7. PubMed ID: 9734113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peri-operative anticoagulation with danaparoid for a patient with Budd-Chiari syndrome and heparin-induced thrombocytopenia].
    Brémaud M; De Maistre E; Junke E; Guerci A; Lalot JM; Longrois D; Lecompte T; Meistelman C
    Ann Fr Anesth Reanim; 2004 Feb; 23(1):50-5. PubMed ID: 14980323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
    Markoski S
    Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.